News & Perspective

Nov 17, 2017

Nov 17, 2017

ASP Scan (Weekly) for Nov 17, 2017

Primary care stewardship
No-touch superbug disinfection
Surgical antimicrobial prescribing
Ceftriaxone-resistant gonorrhea
E coli ST131
Single-room ICU design
ECDC CRE guidance
European research funding
Optimal MDR-TB treatment
Real-time resistance tracker
Salmonella in calves
Drug-resistant malaria controversy
US AMR progress
Antimicrobial use in Northern Ireland
Resistance in space

Nov 03, 2017

Nov 03, 2017

ASP Scan (Weekly) for Nov 03, 2017

Livestock-related MRSA
Antimicrobial stewardship recognition
IV antibiotics for UTIs
MRSA vaccine candidate
MCR-1 in pigs
MRSA and patient-sharing
Pneumonia overprescribing
New CARB-X funding
Hospital ASPs
Wales superbug deaths decline
Antibiotics in nursing homes

Feb 17, 2017

Feb 17, 2017

News Scan for Feb 17, 2017

Zika birth defects
More yellow fever
Limiting dengue
Malaria in the Americas
H5N8 outbreaks

Nov 10, 2016

Nov 10, 2016
cystic fibrosis

Study describes spread of drug-resistant bug that infects cystic fibrosis patients

The bacterium may have recently evolved to spread person to person, as it becomes more virulent.

Dec 16, 2011

Dec 16, 2011

Flu watchdogs report few hot spots

(CIDRAP News) – Flu activity remained low in the Northern Hemisphere last week, with only a few countries, such as Costa Rica and Cameroon, reporting spikes in the number of cases, the World Health Organization (WHO) said today.

Costa Rica is the only tropical country in the Americas to report increasing numbers of cases, which are primarily influenza A/H3N2, the WHO said.

Jul 02, 2009

Jul 02, 2009

Studies: Novel H1N1 affects deep lung tissue, transmits fairly well

(CIDRAP News) – The novel H1N1 (swine) influenza now circling the globe causes more serious lung disease than seasonal flu strains and sheds from the lung and throat tissue where it reproduces at higher rates, according to two animal studies published today—findings that could explain autopsies and case reports of severe pneumonia as well as the virus's rapid spread.

Jan 20, 2006

Jan 20, 2006

Report discourages use of antivirals for seasonal flu

Jan 20, 2005 (CIDRAP News) – Researchers who analyzed numerous clinical trials concluded that the two newest antiviral drugs for influenza, oseltamivir (Tamiflu) and zanamivir (Relenza), should not routinely be used against seasonal flu—a recommendation flatly rejected by the manufacturer of oseltamivir.

Sort Results

 

Narrow results

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»